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Synthesis and Pharmacological 
Profile of Benzimidazoles
Kantharaju Kamanna
Abstract
Benzimidazoles are a class of heterocyclic, aromatic compounds which share 
a fundamental structural characteristic of six-membered benzene fused to five-
membered imidazole moiety. Molecules having benzimidazole motifs showed 
promising application in biological and clinical studies. Nowadays it is a moiety 
of choice which possesses many pharmacological properties extensively explored 
with a potent inhibitor of various enzymes involved in a wide range of therapeutic 
uses which are antidiabetic, anticancer, antimicrobial, antiparasitic, analgesics, 
antiviral, and antihistamine, as well as used in cardiovascular disease, neurology, 
endocrinology, ophthalmology, and more. The increased interest for benzimidazole 
compounds has been due to their excellent properties, like increased stability, bio-
availability, and significant biological activity. This book chapter mainly discussed 
recent synthetic methods developed for the benzimidazole derivatives and their 
pharmacological properties exemplified on several derivatives.
Keywords: benzimidazole, heterocycle, medicinal chemistry,  
structure activity relationship, biological activity
1. Introduction
The biological application of benzimidazole nucleus is discovered way back 
1944, when Woolley speculated that benzimidazoles resemble purine-like struc-
ture and elicit some biological application [1]. Hence benzimidazole structure 
found isosters of naturally occurring nucleotides, which allows them to con-
tact easily with the biopolymers of the living system. Later, Brink discovered 
5,6-dimethylbenzimidazole as a degradation product of vitamin B12 and subse-
quently found some of its analogs having vitamin B12-like activity [2, 3]. These 
initial study reports emerged to explore various decorated benzimidazole motif 
discoveries by the medicinal chemist. Over the few decades of active research, 
benzimidazole has evolved as an important heterocyclic nucleus due to its wide 
range of pharmacological applications. Hence, it’s worth to understand the basic 
chemistry and structure of such a wonderful molecule. Benzimidazole is formed 
by the fusion of benzene and imidazole moiety, and numbering system accord-
ing to the IUPAC is depicted in Figure 1. Historically, the first benzimidazole was 
prepared in 1872 by Hoebrecker, who obtained 2,5 (or 2,6)-dimethylbenzimidazole 
by the reduction of 2-nitro-4-methylacetanilide [4]. Benzimidazoles which contain 
a hydrogen atom attached to nitrogen in the 1-position readily tautomerize, and 
this may be depicted in Figure 1. This basic “6 + 5” heterocyclic structure is shared 
by another class of chemical compounds existing in nature shown in Figure 2. 
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Figure 3. 
Benzimidazole-based drugs.
Among the members of this group of molecules are well-known building blocks for 
biopolymers, such as adenine and guanine, two of the five nucleic acid bases, uric 
acid, and caffeine. From this basic structural similarity, it is not too surprising that 
benzimidazole nucleus has emerged biologically as an important pharmacophore 
with a privileged structure in medicinal chemistry. Nowadays it is a moiety of 
choice which possesses many pharmacological properties. The most prominent 
benzimidazole compound in nature is N-ribosyl-dimethylbenzimidazole, which 
serves as an axial ligand for cobalt in vitamin B12. The pharmacological application 
of benzimidazole analogs found potent inhibitors of various enzymes involved and 
therapeutic uses including as antidiabetic, anticancer, antimicrobial, antiparasitic, 
analgesics, antiviral, antihistamine, and also neurological, endocrinological, and 
ophthalmological drugs [5–13].
The use of benzimidazole started many years back in 1990 onward, a vast number 
of benzimidazole analogs synthesis were reported, which resulted in increased stabil-
ity, bioavailability, and significant biological activity. Some of the well-known active 
drugs with benzimidazole ring are mentioned in Figure 3, omeprazole, bendamustine, 
Figure 1. 
Tautomeric forms of benzimidazole.
Figure 2. 
Common biomolecules with a “6 + 5” heterocyclic structure.
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albendazole, and mebendazole. This chapter is mainly focused on the chemistry of the 
benzimidazoles and on the recently reported synthesis and mechanisms, structural 
aspects, and pharmacological applications with biological and clinical studies.
2. Overview of benzimidazole synthesis
Experimentally the simple method for the synthesis of benzimidazole deriva-
tives begin with benzene containing nitrogen functions at ortho-position to each 
other o-phenylenediamine (OPD) is well documented. In this section several 
synthetic methodologies are grouped according to the starting material which is 
used for the benzimidazole motif synthesis reviewed.
2.1  Synthesis of benzimidazoles by the reaction of substituted aldehyde 
 with OPD
The reaction of OPD with aromatic/aliphatic aldehyde under suitable condition 
for the synthesis of 2-substituted benzimidazoles is well-known. Since the reaction 
involved oxidation, it required oxidative condition. The oxidation reaction may be 
carried out in the presence of air or more conveniently by oxidizing agent such as 
cupric acetate first introduced by Weidenhagen [14–16]. This method reported the 
reaction of OPD with aldehyde in the presence of water or alcoholic solution in the 
presence of cupric acetate. The formed cuprous salt of benzimidazole is decomposed 
with hydrogen sulfide which gave free benzimidazole after filtration. This method 
isolated excellent yields of 2-substituted benzimidazoles of alkyl, aryl, and heterocy-
clic substituted moiety. Further Wright’s group reported the synthesis of N-alkylated 
benzimidazoles using N-alkylated-o-phenylenediamine with aldehydes gave good 
yields of 1-substituted benzimidazole. The mechanism found the initial formation 
of a Schiff intermediate by the reaction of aldehyde with one of the amines of OPD, 
followed by cyclization to form the product (Figure 4). The researcher observed 
that, the reaction between OPD and aldehyde in the absence of a specific oxidizing 
agent results to either 2-substituted benzimidazoles or aldimines (Figure 5) product 
formation in some cases aldimines major and some cases 2-substituted benzimid-
azoles are the major or both form exists in equal amounts. Rao and Smith et al. inde-
pendently reviewed the reaction between OPD and Aldehydes (Figure 6) as a simple 
and efficient method to synthesize benzimidazoles [17, 18]. Numerous methods 
Figure 4. 
Mechanism of formation of benzimidazole catalyzed by oxidizing agent [PhI (OAc)2 ].
Figure 5. 
Synthesis of benzimidazoles via aldiminic intermediates in the absence of catalyst.
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Figure 7. 
Synthesis of benzimidazole starting OPD with acyl chloride derivatives.
Figure 8. 
Synthesis of benzimidazoles starting o-nitroarylamines.
are reported for the condensation of substituted OPD with aryl/alkyl/heterocyclic 
aldehydes catalyzed by different oxidizing agents or metal triflate such as Sc (OTf)3 
or Yb (OTf)3 [19], sulfamic acid [20], H2O2-HCl [21], FeBr3 [22], PhI (OAc)2 [23], 
LaCl3 [24], H5IO6-SiO2 [25], Ce (NO3)3.6H2O [26], NaHSO4-SiO2 [27], mercuric oxide 
[28], chloranil [29], manganese dioxide [30], and I2/TBHP [31] and more methods 
[32–34]. This method isolated excellent yields of 2-substituted benzimidazoles with 
alkyl, aryl, and heterocyclic substituted moiety (Figure 6).
2.2  Synthesis of benzimidazoles by the reaction of aryl/alkyl/heterocyclic acid 
chloride with OPD
Other synthetic routes involved carboxylic acid with an OPD-required harsh 
condition in the presence of a strong acid at elevated temperatures with poor yield 
reported for the benzimidazole. Alternatively, a two-step synthesis is reported, 
wherein the OPD is treated with one equivalent of an acid chloride derivative and 
the resulting mono-acylated product is subjected to cyclodehydration under various 
conditions such as heating in aqueous acids/solvents or by greener methods such as 
glycerol [35], ionic liquid [Hbim] BF4 [36], agro-waste extract WEPBA [37], hetero-
polyacid [38], BF3.Et2O [39], zeolite [40], KF-Al2O3 [41], and more (Figure 7).
2.3  Synthesis of benzimidazoles by the reaction of substituted alcohol or amines 
with o-nitroarylamines
Researcher demonstrated alternative substrate o-nitroarylamine reaction with 
substituted alcohol or amines by using various reducing/redox agents (FeCl3) for 
the synthesis of benzimidazole in a single step. This procedure has got commercial 
importance due to reasonable yield isolation (Figure 8) [42–44].
Figure 6. 
Synthesis of benzimidazole derivatives from OPD and aldehydes.
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2.4  Synthesis of benzimidazoles by the reaction of aldehyde or EAA with 
o-substituted arylamines
One-pot three-component reaction of 2-haloanilines, aldehydes, and NaN3 is 
also reported for the synthesis of benzimidazole [45]. The reaction catalyzed CuCl 
(5 mol%), and 5 mol% of TMEDA was reacted in DMSO at 120°C which gave the 
product good yields (4a). The reaction showed tolerance toward aliphatic, hetero-
cyclic aldehydes, and functional groups such as ester, nitro, and chloro on aromatic 
afforded the desired products in moderate yields. Bahrami et al. reported useful syn-
thetic methodology for the synthesis of benzimidazoles using catalytic redox cycling 
based on (Ce(IV)/Ce(III))/H2O2 redox-mediated oxidation of the Schiff intermedi-
ate derived from differently substituted aromatic 1,2-phenylendiamines/2-thiol with 
a variety of aromatic aldehydes which resulted in isolation of the product in good 
yield (4b) [46]. Further, Bao et al. found Brønsted acid-catalyzed (TsOH) cycliza-
tion reactions of 2-amino anilines with ethylacetoaceate (EAA) under oxidant-, 
metal-, and radiation-free conditions (4c). In this method various 2-substituted 
benzimidazoles are obtained with different groups such as methyl, chloro, nitro, and 
methoxy linked on benzene rings which were tolerated (Figure 9) [47].
2.5  Synthesis of benzimidazoles by C-H amination of N-substituted amidines
Researcher demonstrated oxidative C-H amination of N”-aryl-N’-tosyl/N’-
methylsulfonylamidines and N,N’-bis(aryl)amidines using iodobenzene as a 
catalyst to obtain 1,2-disubstituted benzimidazoles in the presence of m-CPBA 
which gave target product moderate to high yields (5a) [48]. Alternatively, other 
research group reported intramolecular N-arylations of amidines mediated by 
KOH in DMSO at 120°C (5b). The method allows diversely substituted products in 
moderate to very good yields (Figure 10) [49].
Figure 10. 
Synthesis of benzimidazoles using N-substituted amidines.
Figure 9. 
One-pot three-component reaction for the synthesis of benzimidazole.
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Figure 11. 
Synthesis of 2-substituted (hetero)aryl benzimidazoles.
Figure 12. 
N-Substituted formamides as C1 sources for the synthesis of benzimidazole.
2.6  Functionalization of benzimidazole to 2-substituted (hetero)aryl 
benzimidazole
Shao et al. recently reported the synthesis of benzimidazoles via direct C−H 
bond arylation in the presence of a NHC-Pd(II)-Im complex. The method is toler-
able to various activated and deactivated (hetero)aryl chlorides to get 2-(hetero)
aryl benzimidazoles in high yields. It is a facile and an alternative methodology for 
the direct C−H bond arylation of (benz)imidazoles (Figure 11) [50].
2.7  Synthesis by the reaction of N-substituted formamides with OPD derivatives
Bhanage et al. demonstrated efficient and convenient one-pot protocol 
synthesis of a benzimidazole derivative using various OPD derivatives and 
N-substituted formamides (C1 sources) in a zinc acetate-catalyzed cyclization in 
the presence of poly(methylhydrosiloxane) to afford corresponding products in 
good yields (Figure 12) [51].
Figure 14. 
Synthesis of 1,2-disubstituted benzimidazole.
Figure 13. 
One-pot three-component reaction.
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2.8  Synthesis by one-pot three-component reaction
Punniyamurthy’s group reported copper-catalyzed one-pot, three-component 
reaction of N-aryl imines, in which imine acts as a directing group by chelating to the 
metal center, which affords a potential route for the transformation of the commercial 
aryl amines, aldehydes, and azides into valuable benzimidazole with vast substrate 
scope and diversity (8a). Further, the same group is reported in copper(II)-catalyzed 
oxidative cross-coupling of anilines, primary alkyl amines, and sodium azide in the 
presence of TBHP at moderate temperature (8b). This one-pot protocol involves 
a domino C-H functionalization, transamination, ortho-selective amination, and 
cyclization sequence. The method is found tolerable to broad functional group and 
can be extended to the coupling of benzyl alcohols (Figure 13) [52, 53].
2.9 Synthesis of 1,2-disubstituted benzimidazole
Chang et al. demonstrated intramolecular C−H amidation using molecular 
iodine under basic conditions. The imine substrates required were readily prepared 
by condensation of aldehydes with OPD derivatives. The reaction is carried out in 
the absence of metal-free cyclization, works well with crude imines, and allows 
synthesis of series of N-substituted benzimidazoles. This method is tolerable to a 
variety of aromatic, aliphatic, and cinnamic aldehydes to produce diverse  
1,2-disubstituted benzimidazoles (Figure 14) [54].
3. Pharmacological profile of benzimidazole derivatives
Benzimidazole moiety came in scenic after discovery of it as an integral part of the 
structure of the vitamin B12 in the 1950s. In the early 1960s, it was developed as plant 
fungicides and later as veterinary anthelminthic. Further, a variety of veterinary anthel-
mintics were developed and marketed, including parbendazole, fenbendazole, oxfen-
dazole, and cambendazole. In 1962 the first benzimidazole developed and licensed for 
human use was thiabendazole, and present more derivatives of benzimidazole that have 
been clinically approved are albendazole, mebendazole, and flubendazole as anthelmin-
tic; omeprazole, lansoprazole, and pantoprazole as proton pump inhibitors; astemizole 
as antihistaminic; enviradine as antiviral; and candesartan cilexetil and telmisartan 
as antihypertensives. In literature various substituted derivatives of benzimidazole 
demonstrated various therapeutic agents such as anticancer, antiproliferative,  
antimicrobials, antivirals, antiparasites, anthelmintic activity, anticonvulsant, antioxi-
dants, anti-inflammatory, antihypertensive, immunomodulators, proton pump inhibitors, 
anticoagulants, hormone modulators, and CNS stimulants as well as antidepressants, 
antidiabetics, anti-HIV, lipid level modulators, etc. and have made an important scaffold 
for the development of new therapeutic agents (Figure 15) [10, 12, 13, 55–79].
3.1 Anticancer activity
Yang et al. optimized the solubility problem of lead benzimidazole (1) through 
introducing N-methylpiperazine groups at the 2-position showing preliminary 
in vitro anticancer activities [80]. Raghavan et al. demonstrated synthesis and evalu-
ation of 1-(4-methoxyphenethyl)-1H-benzimidazole-5-carboxylic acid derivatives 
(2). Caused maximum cell death in leukemic cells with a micromolar concentra-
tion [81]. Omar et al. demonstrated synthesis and docking studies of new series 
benzimidazole-pyrrole and tetracycline conjugates (3) tested against lung cancer 
cell line A549 and breast cancer cell line MCF-7 and found these molecules exhibited 
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Figure 15. 
Pharmacological profile of benzimidazole nucleus.
Figure 16. 
Benzimidazole derivatives with anticancer effect.
remarkable higher activity than standard [82]. Karthikeyan et al. discovered deriva-
tives of benzimidazoles 2-(phenyl)-3H-benzo[d]imidazole-5-carboxylic acids (4) 
and its methyl esters for anti-breast cancer agents [83]. Yoon et al. demonstrated 
novel benzimidazole derivatives (5) in sirtuin inhibitors (SIRT1 and SIRT2) with 
antitumor activities [84]. El-Nassan’s group showed novel 1,2,3,4-tetrahydro[1,2,4]
triazino[4,5-a]benzimidazole (6) analogs of aryl and heteroaryl groups showing 
antitumor activity in human breast adenocarcinoma cell line (MCF-7) [85]. Singh 
and Tandon demonstrated 2-aryl-substituted 2-bis-1H-benzimidazoles (7) evaluated 
as a topoisomerase-I inhibitor, and more benzimidazole derivatives are in line for the 
development of drug candidates (Figure 16) [86, 87].
3.2 Antiviral activity
Benzimidazole and its derivatives showed antiviral activity via contact with differ-
ent virus particles such as human cytomegalovirus (HCMV), human herpes simplex 
virus (HSV-1), human immunodeficiency virus (HIV), and hepatitis-B and hepatitis-
C virus (HBV and HCV). Luo et al. demonstrated the hepatitis-B virus inhibition by 
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novel benzimidazole derivatives (8) in HepG2.2.15 cell line [88]. Gudmundsson et al. 
discovered alkyl and cyclic alkyl amine substituted N-(1H-benzimidazol-2-ylmethyl)-
5,6,7,8-tetrahydro-8-quinolinamines (9) and screened them for anti-HIV-1 activity 
as CXCR4 antagonists [89]. Miller et al. demonstrated stereochemically defined 
N-substituted benzimidazoles containing cyclic alkyl amine side chains (10), and its 
SAR analogs showed CXCR4 antagonist activity as anti-HIV agents [90]. Beaulieu et al. 
demonstrated few benzimidazole-based allosteric inhibitors (11) that bind to thumb 
pocket I of the HCV NS5B polymerase inhibition to HCV NS5B [91]. In another work, 
Wubulikasimu et al. evaluated a series of benzimidazoles bearing a heterocyclic ring as 
oxadiazole, thiadiazole, and triazole (12) for their inhibition against Coxsackieviruses 
B3 and B6 in Vero cells [92]. Monforte et al. reported N-1-aryl-benzimidazole 2-sub-
stituted analogs (13) inhibit HIV-1 nonnucleoside reverse transcriptase inhibitors 
(NNRTIs) [93]. Some of these analogs inhibited the replication of HIV at nanomolar 
concentration with low cytotoxicity (Figure 17) [94].
4. Conclusions
The modern drug discovery more emphasizes on benzimidazole nucleus con-
taining pharmacophore extensively applied in the biological and clinical studies. 
In this book chapter reviewed, recent optimized synthetic methods reported by 
various research groups for the synthesis of benzimidazole derivatives are exem-
plified. Further, the therapeutic use of benzimidazole in important areas such as 
antidiabetic, anticancer, antimicrobial, antiparasitic, analgesics, antiviral, antihis-
tamine, and more is discussed. In spite of the active, exhaustive, and target-based 
research on the development of many drug-like molecule development, the number 
of molecules that made its way to the market and clinic is not measurable. It can be 
probably due to lack of a comprehensive compilation of various research reports 
in each activity capable of giving an insight into the SAR of the compounds. The 
biological profiles of these new generations of benzimidazole would represent a 
fruitful matrix for further development of better medicinal agents.
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2-PrOH 2-propanol
AcOH acetic acid
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CAN ceric ammonium nitrate
CH3CN acetonitrile
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CuCl copper chloride
CuI copper iodide
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H5IO6-SiO2 silica-supported periodic acid
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HFIP 1,1,1,3,3,3-hexafluoro-2-propanol
I2 iodine
KOH potassium hydroxide
KOtBu potassium tertiary butoxide
m-CPBA m-chloroperoxybenzoic acid
NaN3 sodium azide
NH4Cl ammonium chloride
OPD o-phenylenediamine
PhI(OAc)2 benzene (diacetoxyiodo)
PhI iodobenzene
PMHS poly(methylhydrosiloxane)
r.t room temperature
SAR structure activity relationship
TBHP tert-butyl hydroperoxide
TMEDA N,N,N’,N’-tetramethylethylenediamine
TMSN3 trimethylsilyl azide
TsOH p-toluene sulfonic acid
WEPBA water extract of papaya bark ash
Zn(OAc)2 zinc acetate
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